Abstract:AIMS Cardiac hypertrophy is characterized by a shift in metabolic substrate utilization, but the molecular events underlying the metabolic remodelling remain poorly understood. We explored metabolic remodelling and mitochondrial dysfunction in cardiac hypertrophy and investigated the cardioprotective effects of choline. METHODS AND RESULTS The experiments were conducted using a model of ventricular hypertrophy by partially banding the abdominal aorta of Sprague Dawley rats. Cardiomyocyte size and cardiac fibrosis were significantly increased in hypertrophic hearts. In vitro cardiomyocyte hypertrophy was induced by exposing neonatal rat cardiomyocytes to angiotensin II (Ang II) (10-6 M, 24 h). Choline attenuated the mito-nuclear protein imbalance and activated the mitochondrial-unfolded protein response (UPRmt) in the heart, thereby preserving the ultrastructure and function of mitochondria in the context of cardiac hypertrophy. Moreover, choline inhibited myocardial metabolic dysfunction by promoting the expression of proteins involved in ketone body and fatty acid metabolism in response to pressure overload, accompanied by the activation of sirtuin 3/AMP-activated protein kinase (SIRT3-AMPK) signalling. In vitro analyses demonstrated that SIRT3 siRNA diminished choline-mediated activation of ketone body metabolism and UPRmt, as well as inhibition of hypertrophic signals. Intriguingly, serum from choline-treated abdominal aorta banding models (where β-hydroxybutyrate was increased) attenuated Ang II-induced myocyte hypertrophy, which indicates that β-hydroxybutyrate is important for the cardioprotective effects of choline. CONCLUSION Choline attenuated cardiac dysfunction by modulating the expression of proteins involved in ketone body and fatty acid metabolism, and induction of UPRmt; this was likely mediated by activation of the SIRT3-AMPK pathway. Taken together, these results identify SIRT3-AMPK as a key cardiac transcriptional regulator that helps orchestrate an adaptive metabolic response to cardiac stress. Choline treatment may represent a new therapeutic strategy for optimizing myocardial metabolism in the context of hypertrophy and heart failure.

Amelioration of circadian disruption and calcium-handling protein defects by choline alleviates cardiac remodeling in abdominal aorta coarctation rats

Alteration of mevalonate pathway related enzyme expressions in pressure overload-induced cardiac hypertrophy and associated heart failure with preserved ejection fraction.

Theoretical Investigation Of The Mechanism Of Heart Failure Using A Canine Ventricular Cell Model: Especially The Role Of Up-Regulated Camkii And Sr Ca2+ Leak

Choline Ameliorates Cardiac Hypertrophy by Regulating Metabolic Remodelling and UPRmt Through SIRT3-AMPK Pathway

Choline ameliorates cardiovascular damage by improving vagal activity and inhibiting the inflammatory response in spontaneously hypertensive rats

Cardiac contractility modulation attenuates structural and electrical remodeling in a chronic heart failure rabbit model

Effect of Calcium-Sensing Receptor Inhibition on the Vulnerability of Ventricular Arrhythmia in a Rat Model of Chronic Heart Failure

Suppression of Cardiac Sympathetic Ganglion Attenuates Cardiac Remodeling in a Circadian Disruption Model

Choline Protects the Heart from Doxorubicin-Induced Cardiotoxicity Through Vagal Activation and Nrf2/HO-1 Pathway

Improving Vagal Activity Ameliorates Cardiac Fibrosis Induced by Angiotensin Ii: in Vivo and in Vitro

Sympathetic Nervous System Mediates Cardiac Remodeling After Myocardial Infarction in a Circadian Disruption Model

Alterations of Calcium Channels and Cell Excitability in Intracardiac and Stellate Ganglion Neurons from Chronic Heart Failure Rats

Activation Of M3achr (Type 3 Muscarinic Acetylcholine Receptor) And Nrf2 (Nuclear Factor Erythroid 2-Related Factor 2) Signaling By Choline Alleviates Vascular Smooth Muscle Cell Phenotypic Switching And Vascular Remodeling

Dietary Choline Deprivation Exacerbates Cardiomyopathy in Streptozotocin-Induced Diabetic Adult Rats

Cardiac-Specific Overexpression of Caveolin-1 in Rats with Ischemic Cardiomyopathy Improves Arrhythmogenicity and Cardiac Remodeling

Astragaloside IV inhibits ventricular remodeling and improves fatty acid utilization in rats with chronic heart failure

THE MECHANICAL EFFECTS OF CARDIAC RESYNCHRONIZATION THERAPY PROMOTING AUTOPHAGY VIA MITOCHONDRIAL CALCIUM UNIPORTER DOWN-REGULATION AND MITOCHONDRIAL DYNAMICS ALTERATION

Heart failure-induced changes of voltage-gated Ca2+ channels and cell excitability in rat cardiac postganglionic neurons.

Cardamonin Alleviates Pressure Overload-induced Cardiac Remodeling and Dysfunction Through Inhibition of Oxidative Stress.

Chai-Hu-San-Shen Capsule Ameliorates Ventricular Arrhythmia Through Inhibition of the CaMKII/FKBP12.6/RyR2/Ca2+ Signaling Pathway in Rats with Myocardial Ischemia

Catechin ameliorates cardiac dysfunction in rats with chronic heart failure by regulating the balance between Th17 and Treg cells